Regeneron Pharmaceuticals... (REGN)
685.26
-13.48 (-1.93%)
At close: Mar 03, 2025, 3:59 PM
684.00
-0.18%
After-hours: Mar 03, 2025, 04:09 PM EST
Regeneron Pharmaceuticals Income Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 | FY95 | FY94 | FY93 | FY92 | FY91 | FY90 |
Revenue | 14.2B | 13.12B | 12.17B | 16.07B | 8.5B | 7.86B | 6.71B | 5.87B | 4.86B | 4.1B | 2.82B | 2.1B | 1.38B | 445.82M | 459.07M | 379.27M | 238.46M | 125.02M | 63.45M | 66.19M | 174.02M | 57.5M | 21.99M | 21.97M | 59.28M | 34.5M | 38.2M | 33.1M | 24.1M | 27.4M | 23.2M | 10.6M | 11.5M | 7.3M | 5M |
Cost of Revenue | 1.97B | 1.82B | 1.56B | 2.44B | 1.12B | 782.2M | 434.1M | 397.06M | 299.69M | 392.71M | 205.02M | 155.35M | 84.45M | 4.22M | 2.09M | 1.69M | 923K | n/a | 8.15M | 9.56M | 15.21M | 6.68M | 6.48M | 6.51M | 15.57M | 3.6M | 5M | 2.6M | 1.1M | n/a | n/a | n/a | n/a | 12.8M | 6.3M |
Gross Profit | 12.23B | 11.3B | 10.61B | 13.63B | 7.38B | 7.08B | 6.28B | 5.48B | 4.56B | 3.71B | 2.61B | 1.95B | 1.29B | 441.61M | 456.98M | 377.58M | 237.53M | 125.02M | 55.3M | 56.64M | 158.8M | 50.82M | 15.51M | 15.46M | 43.71M | 30.9M | 33.2M | 30.5M | 23M | 27.4M | 23.2M | 10.6M | 11.5M | -5.5M | -1.3M |
Operating Income | 3.99B | 4.05B | 4.74B | 8.95B | 3.58B | 2.21B | 2.53B | 2.08B | 1.33B | 1.25B | 838.43M | 760.03M | 457.71M | -205.16M | -97.47M | -74.1M | -89.83M | -114.45M | -107.66M | 124.42M | 5.65M | -99.99M | -121.95M | -85.68M | -25.28M | -23.8M | -12.6M | -7.5M | -17.3M | -7.6M | -29.2M | -38.8M | -18.3M | -9.6M | -3.3M |
Interest Income | 711.4M | 495.9M | 160.1M | 45.8M | 18.5M | 30.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 4.78B | 4.2B | 4.86B | 9.33B | 3.81B | 2.43B | 2.55B | 2.08B | 1.33B | 1.23B | 775.75M | 713.36M | 414.42M | -222.89M | -104.47M | -71.95M | -80.36M | -93.56M | -91.11M | 124.42M | 53.87M | -95.53M | -112.52M | -73.52M | -29.85M | -22.8M | -8.2M | -7.5M | -17.3M | -7.6M | n/a | n/a | n/a | -4.4M | n/a |
Net Income | 4.41B | 3.95B | 4.34B | 8.08B | 3.51B | 2.12B | 2.44B | 1.2B | 895.52M | 636.06M | 348.07M | 424.36M | 750.27M | -221.76M | -104.47M | -67.83M | -82.71M | -105.6M | -102.34M | -95.45M | 41.7M | -107.46M | -124.38M | -76.18M | -23.21M | -23.1M | -8.6M | -11.6M | -32.4M | -23.5M | -30.7M | -39.9M | -19.1M | -4.5M | -3.3M |
Selling & General & Admin | 2.95B | 2.63B | 2.12B | 1.82B | 1.35B | 1.83B | 1.56B | 1.32B | 1.18B | 838.53M | 504.75M | 329.42M | 210.75M | 117.26M | 65.2M | 52.92M | 49.35M | 37.87M | 25.89M | 25.48M | 17.06M | 14.79M | 12.53M | 9.61M | 8.31M | 6.4M | 5.8M | 5.8M | 5.9M | 5.8M | 8.5M | 46.3M | 27.8M | 3.3M | 1.7M |
Research & Development | 5.13B | 4.44B | 3.59B | 2.91B | 2.73B | 3.04B | 2.19B | 2.08B | 2.05B | 1.62B | 1.27B | 859.95M | 625.55M | 529.51M | 489.25M | 398.76M | 278.02M | 201.61M | 137.06M | 155.58M | 136.09M | 136.02M | 124.93M | 91.54M | 56.26M | 44.9M | 37M | 27.8M | 28.3M | 23.3M | 39.7M | n/a | n/a | n/a | n/a |
Other Expenses | 154.4M | n/a | -89.9M | -45.6M | -280.4M | 219.3M | 19.1M | -1.08M | -926K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -248.84M | n/a | n/a | n/a | n/a | 4.42M | 3.4M | 3M | 4.4M | 6.1M | 5.9M | 4.2M | 3.1M | 2M | 800K | 300K |
Operating Expenses | 8.24B | 7.25B | 5.62B | 4.69B | 3.8B | 4.87B | 3.74B | 3.4B | 3.23B | 2.46B | 1.78B | 1.19B | 836.31M | 646.77M | 554.45M | 451.69M | 327.36M | 239.48M | 162.96M | -67.78M | 153.16M | 150.81M | 137.46M | 101.15M | 68.99M | 54.7M | 45.8M | 38M | 40.3M | 35M | 52.4M | 49.4M | 29.8M | 4.1M | 2M |
Interest Expense | 55.2M | 73M | 59.4M | 57.3M | 56.9M | 30.2M | 28.2M | 25.12M | 7.2M | 14.24M | 37.37M | 46.44M | 45.3M | 21.28M | 9.12M | 2.34M | 7.75M | 12.04M | n/a | n/a | n/a | n/a | n/a | n/a | 4.58M | n/a | n/a | 3.4M | 14.3M | 14.7M | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.21B | 9.07B | 7.18B | 7.12B | 4.92B | 5.65B | 4.18B | 3.79B | 3.53B | 2.85B | 1.98B | 1.34B | 920.76M | 650.98M | 556.55M | 453.37M | 328.29M | 239.48M | 171.1M | -58.23M | 168.37M | 157.49M | 143.94M | 107.66M | 84.55M | 58.3M | 50.8M | 40.6M | 41.4M | 35M | 52.4M | 49.4M | 29.8M | 16.9M | 8.3M |
Income Tax | 367.3M | 245.7M | 520.4M | 1.25B | 297.2M | 313.3M | 109.1M | 880M | 434.29M | 589.04M | 427.67M | 289M | -335.85M | -1.13M | -2.12M | -4.12M | 2.35M | -29.75M | -21.87M | 178.85M | -84.28M | 3.01M | -7.01M | -21.66M | 2.51M | -1.7M | -8.4M | 7.5M | 29.4M | 30.6M | 1.5M | 1.1M | 800K | -10.3M | n/a |
Shares Outstanding (Basic) | 107.9M | 106.7M | 107.1M | 105.7M | 107.6M | 109.2M | 114.8M | 115.9M | 116.25M | 115.23M | 113.41M | 111.22M | 111.07M | 90.61M | 82.93M | 79.78M | 78.83M | 66.33M | 57.97M | 55.95M | 55.42M | 50.45M | 43.95M | 42.09M | 35.17M | 31.22M | 30.71M | 29M | 24.46M | 19.75M | 18.95M | 16.56M | 15.4M | 15.52M | 15.36M |
Shares Outstanding (Diluted) | 115.1M | 113.7M | 113.5M | 112.2M | 115.1M | 114.6M | 114.8M | 115.91M | 116.3M | 115.23M | 113.47M | 111.29M | 115.38M | 90.61M | 82.93M | 79.78M | 78.83M | 66.33M | 57.97M | 55.95M | 56.17M | 50.45M | 43.95M | 42.09M | 35.17M | 31.45M | 31M | 29M | 24.46M | 19.75M | 18.95M | 16.56M | 15.4M | 15.52M | 15.36M |
EPS (Basic) | 40.90 | 37.05 | 40.51 | 76.40 | 32.65 | 19.38 | 21.29 | 11.27 | 8.55 | 6.17 | 3.36 | 4.23 | 7.92 | -2.45 | -1.26 | -0.85 | -1.05 | -1.59 | -1.77 | -1.71 | 0.75 | -2.13 | -2.83 | -1.81 | -0.66 | -0.74 | -0.28 | -0.4 | -1.32 | -1.19 | -1.62 | -2.41 | -1.24 | -0.29 | -0.21 |
EPS (Diluted) | 38.34 | 34.77 | 38.22 | 71.97 | 30.52 | 18.46 | 21.29 | 10.34 | 7.70 | 5.52 | 2.98 | 3.72 | 6.75 | -2.45 | -1.26 | -0.85 | -1.05 | -1.59 | -1.77 | -1.71 | 0.74 | -2.13 | -2.83 | -1.81 | -0.66 | -0.73 | -0.28 | -0.4 | -1.32 | -1.19 | -1.62 | -2.41 | -1.24 | -0.29 | -0.21 |
EBITDA | 5.32B | 4.69B | 5.34B | 9.28B | 3.9B | 2.42B | 2.68B | 2.08B | 1.44B | 1.33B | 876.61M | 784.25M | 496.67M | -170.53M | -75.66M | -55.37M | -61.32M | -82.07M | -93.06M | 139.93M | -27.22M | -91.51M | -113.5M | -79.61M | -20.86M | -20.4M | -9.5M | -9.3M | -11.2M | -1.7M | -25M | -35.7M | -16.3M | -8.8M | -3M |
Depreciation & Amortization | 482.9M | 421M | 341.4M | 286.2M | 235.9M | 210.3M | 148.2M | 145.47M | 104.75M | 74.91M | 52.69M | 41.2M | 36.94M | 31.08M | 19.69M | 14.25M | 11.29M | 11.49M | 14.59M | 15.5M | 15.36M | 12.94M | 8.45M | 6.08M | 4.42M | 3.4M | 3M | 4.4M | 6.1M | 5.9M | 4.2M | 3.1M | 2M | 800K | 300K |